MOONLAKE IMMUNOTHERAPEUTICS Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) had Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax of $319.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax · last filed 2026-02-25
- 2025-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $319.00K.
- 2024-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$322.00K; Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed -$322.14K.
- 2023-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$235.00K; Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed -$234.86K.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $102.00K; Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed $101.72K.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed |
|---|---|---|
| 2025-12-31 | $319.00K 10-K · filed 2026-02-25 | |
| 2024-12-31 | -$322.00K 10-K · filed 2026-02-25 | -$322.14K 10-K · filed 2025-02-26 |
| 2023-12-31 | -$235.00K 10-K · filed 2026-02-25 | -$234.86K 10-K · filed 2024-02-29 |
| 2022-12-31 | $102.00K 10-K · filed 2026-02-25 | $101.72K 10-K · filed 2023-03-20 |
| 2021-12-31 | -$168.18K 10-K · filed 2025-02-26 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |